Skip to content

Palliative care: pain and symptom control being ignored in South Africa due to lack of training, legal barriers

Up to 40% of ART recipients in Africa have died or discontinued treatment within two years

Why are many US patients presenting later for HIV testing and care today than in 1990?

Cluster of 'indolent' KS cases in older, antiretroviral-treated patients in San Francisco

Good virological outcome in patients starting HIV therapy in the UK

Raltegravir receives accelerated approval from the FDA

Stigma surrounding genital herpes a major barrier to disclosure, UK study finds

Studies underway to find the best time to start anti-HIV therapy in those taking TB treatment

Sudden increases in viral load in first two years of infection could indicate superinfection